John Quin

453 total citations
13 papers, 325 citations indexed

About

John Quin is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Quin has authored 13 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Quin's work include Synthesis and Biological Evaluation (3 papers), Cancer therapeutics and mechanisms (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). John Quin is often cited by papers focused on Synthesis and Biological Evaluation (3 papers), Cancer therapeutics and mechanisms (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). John Quin collaborates with scholars based in United States, New Zealand and Israel. John Quin's co-authors include Ellen M. Dobrusin, R J Booth, Dennis J. McNamara, Peter L. Toogood, Joseph T. Repine, Patricia J. Harvey, Paul R. Keller, David W. Fry, William L. Elliott and R. Thomas Winters and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

John Quin

13 papers receiving 311 citations

Peers

Countries citing papers authored by John Quin

Since Specialization

Citations

This map shows the geographic impact of John Quin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Quin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Quin more than expected).

Fields of papers citing papers by John Quin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Quin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Quin. The network helps show where John Quin may publish in the future.

Co-authorship network of co-authors of John Quin

This figure shows the co-authorship network connecting the top 25 collaborators of John Quin. A scholar is included among the top collaborators of John Quin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Quin. John Quin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase 2012 ·Bioorganic & Medicinal Chemistry Letters ·Noel A. Powell, (unknown), Fred L. Ciske, Michael D. Kaufman, Jeffrey T. Kohrt, John Quin, Derek Sheehan, Amy M. Delaney, Sangita M. Baxi, Cornel Catana, Patrick McConnell, Jeffrey F. Ohren, (unknown), Jeremy J. Edmunds	13
2	Synthesis and structure–activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases 2007 ·European Journal of Medicinal Chemistry ·Jeff B. Smaill, Edward N. Baker, R J Booth, Alexander J. Bridges, James M. Dickson, Ellen M. Dobrusin, Ivan Ivanović, Alan J. Kraker, Ho H. Lee, Elizabeth A. Lunney, Daniel F. Ortwine, Brian D. Palmer, John Quin, C.J. Squire, Andrew M. Thompson, William A. Denny	28
3	Binding thermodynamics of substituted diaminopyrimidine renin inhibitors 2006 ·Analytical Biochemistry ·Ronald W. Sarver, (unknown), Wayne L. Cody, Fred L. Ciske, (unknown), S. Donald Emerson, (unknown), Daniel D. Holsworth, Mehran Jalaie, Michael D. Kaufman, (unknown), Patrick McConnell, Noel A. Powell, John Quin, (unknown), Erli Zhang, Igor Mochalkin	34
4	Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4 2005 ·Journal of Medicinal Chemistry ·(unknown), Patricia J. Harvey, Dennis J. McNamara, Joseph T. Repine, Paul R. Keller, John Quin, R J Booth, William L. Elliott, Ellen M. Dobrusin, David W. Fry, Peter L. Toogood	121
5	Conformationally switched-on polyether ionophores 1998 ·Chirality ·Morton Raban, John Quin, (unknown), (unknown), Daniel Kost	2
6	C-Terminal Modifications of Histidyl-N-benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in Mice 1997 ·Journal of Medicinal Chemistry ·Dennis J. McNamara, Ellen M. Dobrusin, Daniele M. Leonard, (unknown), James S. Kaltenbronn, John Quin, Scott K. Bur, C. Thomas, Annette M. Doherty, Jeffrey D. Scholten, Karen K. Zimmerman, (unknown), Richard Gowan, (unknown), Wilbur R. Leopold, Sally Przybranowski, Judith S. Sebolt–Leopold	20
7	Benzofuran derivatives as ETA-selective, non-peptide endothelin antagonists 1997 ·European Journal of Medicinal Chemistry ·(unknown), John Quin, (unknown), S. KLUTCHKO, (unknown), (unknown), (unknown), Anne M. Doherty	12
8	Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-l-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H-imidazole-5-carboxylic acid (CI-996) 1993 ·Journal of Medicinal Chemistry ·Ila Sircar, John C. Hodges, John Quin, Amy Bunker, R. Thomas Winters, Jeremy J. Edmunds, Catherine R. Kostlan, Cleo J. C. Connolly, S. Kesten	5
9	Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists 1993 ·Journal of Medicinal Chemistry ·Ila Sircar, R. Thomas Winters, John Quin, Gina H. Lu, Terry C. Major, Robert L. Panek	12
10	Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors 1992 ·Journal of Medicinal Chemistry ·Annette M. Doherty, Ila Sircar, (unknown), John Quin, R. Thomas Winters, James S. Kaltenbronn, (unknown), Brian L. Batley, (unknown)	52
11	A sterically switched ionophore 1991 ·Tetrahedron Letters ·Morton Raban, John Quin, (unknown)	6
12	1,3-Dipolar cycloaddition of nitrile oxides with 1,4-dihydropyridines and conformational analysis of isoxazolo[5,4-b]pyridines 1989 ·The Journal of Organic Chemistry ·Michael D. Taylor, Richard J. Himmelsbach, (unknown), John Quin, Elizabeth A. Lunney, A. G. Michel	19
13	‘Flipped-out’ ionophores. transCyclohexano pentaethylene glycol diethy ethers 1985 ·Journal of the Chemical Society Chemical Communications ·(unknown), Edwin R. Hortelano, John Quin, Nancy M. P. King, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact